Introduction
Arterial smooth muscle contraction is primarily regulated by cytosolic Ca 2 level ([Ca 2 ]i). Ca 2 binds to calmodulin, and the Ca 2 -calmodulin complex subsequently binds to and activates myosin light chain (MLC) kinase (MLCK), resulting in phosphorylation of MLC. The MLC phosphorylation actiphorylation when compared with depolarization-induced responses at a given [Ca 2 ]i (2). Vasoconstrictor agonists (e.g., norepinephrine (NE)) increase [Ca 2 ]i through the release of Ca 2 from the sarcoplasmic reticulum and the influx of Ca 2 from the extracellular space, which activates MLCK. This action is followed immediately by a decrease in MLCP activity, which increases the Ca 2 sensitivity of myofilaments. The agonist-induced Ca 2 sensitization is ascribed to the activation of the small G-protein RhoA that activates Rho kinase which, in turn, phosphorylates the regulatory subunit (myosin-binding subunit and/or CPI-17) of MLCP and inactivates MLCP. Inactive MLCP cannot dephosphorylate MLC, and so Rho kinase activation removes the MLCP activity, allowing MLCK, and contraction, to dominate (3) (4) (5) (6) .
( )-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamide dihydrochloride, monohydrate (Y-27632) is a specific inhibitor of Rho kinase and reduces the agonist-induced Ca 2 sensitization of smooth muscle contraction (7, 8) . Since this inhibitor decreases the blood pressure in several hypertensive rat models, including spontaneously hypertensive rats (SHR), it is suggested that the Ca 2 sensitization of arterial smooth muscle contraction is involved in the pathophysiology of hypertension (7) . However, the effects of Y-27632 on isolated resistance arteries have never been determined in SHR. The aim of the present study was, therefore, to determine the possible role of the Rho-regulated system of MLCP during arterial contraction in SHR. To this end, the arterial relaxant effects of Y-27632 were compared in endothelium-denuded strips of small and large mesenteric arteries from 13-week-old SHR and normotensive WistarKyoto rats (WKY). For comparison, we also determined the effects of nifedipine, a blocker of L-type Ca 2 channels, in these arteries.
Methods

Preparation of Arterial Strips
Male SHR at 13 weeks (12-14 weeks) of age, i.e., during the early established hypertensive stage, and age-matched WKY were used. They were obtained from the inbred colony maintained in our laboratory. The systolic blood pressure measured by tail-cuff plethysmography (KN-210; Natsume Seisakusho, Tokyo, Japan) was significantly higher in SHR (203 2.1 mmHg, n 36) than in WKY (139 0.6 mmHg, n 36). The body weight was not significantly different between SHR (288 3.3 g, n 36) and WKY (292 2.7 g, n 36). All procedures were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of Graduate School of Medical Sciences, Nagoya City University.
After decapitation, the superior mesenteric vascular bed was dissected away from the intestines and placed in a Krebs solution of the following composition (in mmol/l): NaCl 115.0, KCl 4.7, CaCl2 2.5, MgCl2 1.2, NaHCO3 25.0, KH2PO4 1.2 and dextrose 10.0. As a small artery, the second to third branches (150-250 µm outside diameter) of the superior mesenteric artery were isolated and cut into helical strips (0.4-0.6 mm in width, 5-6 mm in length) (9) (10) (11) . As a large artery, the middle part (0.7-0.9 mm outside diameter) of the superior mesenteric artery was cut into helical strips (0.7-0. 8 7-8 mm) (9, 11) . To avoid the possible influences of the endothelium-derived factors (e.g., relaxing, hyperpolarizing and contracting factors), the endothelium of the strip was removed by gently rubbing the endothelial surface with a cotton swab. Successful removal of the endothelium was confirmed by the inability of acetylcholine (1 µmol/l) to induce a relaxation in strips precontracted with prostaglandin F2α.
Measurement of Isometric Tension
Arterial strips were mounted vertically in water-jacketed muscle baths containing 10 ml Krebs solution. Krebs solutions were maintained at 37°C and aerated with 95% O2 and 5% CO2. The isometric tension was recorded with a forcedisplacement transducer (TB-612T; Nihon Kohden Kogyo, Tokyo, Japan). Strips were stretched passively to optimal length by imposing a resting tension (0.3 g for the small artery and 0.5 g for the large artery) that was determined by a length-passive tension study (9) (10) (11) . In each artery, the length-passive tension studies failed to demonstrate differences in the resting tension between the strips from SHR and WKY (9, 10) . A 60-min equilibration period preceded each experiment.
After equilibration, the contractile responses of the strips to 65.9 mmol/l KCl (K ) Krebs solution (equimolar substitution of Na with K ) were repeated (usually three times) until the responses were reproducible. After washout of the strips with Krebs solution, the effects of Y-27632 were determined with a post-and pre-application protocol. As a post-application protocol, the relaxant effects of Y-27632 were determined in strips precontracted with NE. In this experiment, paired strips from the same animal were used: one strip was used to determine the relaxant effects of Y-27632, and the other strip was used as an indicator for the maintenance of the NE contraction; and the relaxant effects of Y-27632 were then corrected by taking the time-dependent decrease in the NE contraction into consideration. The effects of preapplication of Y-27632 on the concentration-response curve for NE were also determined. In both experiments, the NE contractions were determined in the presence of timolol (0.5 µmol/l), a β-adrenoceptor antagonist. The relaxant effects of Y-27632 were also determined in strips precontracted with 65.9 mmol/l K . In this experiment, the strips were pretreated with phenoxybenzamine (2 µmol/l) to eliminate possible α-adrenoceptor responses to endogenously released NE, and timolol (0.5 µmol/l) was added to the Krebs solution (11) . The relaxant effects of nifedipine (a blocker of L-type Ca 2 channels) were also determined.
Statistical Analysis
The results are expressed as the means SEM (n number of preparations). The Student's t-test for unpaired data was used to determine the significance of differences between means, and values of p 0.05 were considered to indicate statistical significance.
Drugs
L-NE bitartrate, timolol and acetylcholine chloride were purchased from Sigma (St. Louis, USA), papaverine hydrochloride from Wako (Osaka, Japan), phenoxybenzamine hydrochloride from Nacalai Tesque (Kyoto, Japan), and prostaglandin F2α from Ono Pharmaceutical (Osaka, Japan). Y-27632 was a generous gift from Yoshitomi Pharmaceutical Industries (Osaka, Japan), and nifedipine was from Bayer Yakuhin (Osaka, Japan).
Nifedipine (1 mmol/l) was dissolved in 99.5% ethanol, with further dilution in distilled water before use. Phenoxybenzamine (2 mmol/l) was dissolved in 99.5% ethanol. Aqueous stock solutions were prepared for other drugs. Concentrations of drugs are expressed as final molar concentrations.
Results
Relaxation Induced by Y-27632 in NE-Contracted Strips of Small Arteries
Addition of 65.9 mmol/l K to strips of small mesenteric arteries caused an initial peak followed by a tonic contraction (Fig. 1) . The peak contraction was significantly larger in SHR (297 9 mg, n 85) than in WKY (269 8 mg, n 85). After washout, the addition of 10 5 mol/l NE caused an initial peak followed by a tonic contraction (Figs. 1A and 2A). When the NE contractions are expressed as a % of the 65.9 mmol/l K contraction, the NE contraction was not significantly different between SHR and WKY ( Fig. 2A) . The application of Y-27632 (0.3-10 µmol/l) to the tonic contraction of these strips caused a concentration-dependent relaxation (Figs. 1B and 3, Table 1 ). The relaxation was greater in SHR than in WKY (Fig. 3 , Table 1 ).
The addition of 10 6 mol/l NE also caused an initial peak followed by a tonic contraction that was not significantly different between the two strains (Figs. 1C and 2B). The post-application of Y-27632 (0.3-3 µmol/l) also caused a concentration-dependent relaxation in these strips and the relaxation was greater in SHR than in WKY (Figs. 1D and 3, Table 1 ).
The addition of 10 7 mol/l NE caused a relatively transient contraction that was not significantly different between the two strains (Figs. 1E and 2C).
Relaxation Induced by Y-27632 in NE-Contracted Strips of Large Arteries
Addition of 65.9 mmol/l K to strips of large mesenteric arteries caused a sustained contraction that was not significantly different between SHR (404 14 mg, n 84) and WKY (383 13 mg, n 84). After washout, the addition of 10 5 mol/l NE caused a relatively sustained contraction (Fig. 4A) . The NE contraction, expressed as a % of the 65.9 mmol/l K contraction, was significantly larger in SHR than in WKY (Fig. 4A) . The application of Y-27632 (0.3-10 µmol/l) to these strips caused a concentration-dependent relaxation that was greater in SHR (Fig. 5 , Table 1 ).
The addition of 10 6 mol/l NE also caused a relatively
Fig. 1. Typical recordings of the contractile responses to norepinephrine (NE) and the Y-27632-induced relaxations in strips of small mesenteric arteries from SHR. After determination of the maximum contraction induced by 65.9 mmol/l K (65.9 K ), NE at a concentration of 10 5 mol/l (A, B), 10 6 mol/l (C, D) or 10 7 mol/l (E) was added. (A, C, E) Contractile responses to NE. (B, D) Y-27632-induced relaxations. After the NE-induced contraction had reached a tonic phase, Y-27632 was added cumulatively. At the end of each experiment, 10
4 mol/l papaverine (Pap) was added to identify the position of the maximum relaxation.
sustained contraction that was not significantly different between the two strains ( Fig. 4B ). Y-27632 (0.3-3 µmol/l) also caused a concentration-dependent relaxation that was greater in SHR (Fig. 5 , Table 1 ).
The addition of 10 7 mol/l NE also caused a relatively sustained contraction and the peak contraction was significantly less in SHR (Fig. 4C) . Y-27632 (0.3 and 1 µmol/l) also caused a concentration-dependent relaxation that was greater in SHR (Fig. 5, Table 1 ).
Judging from the concentrations of Y-27632 needed to induce a 50% relaxation (Table 1) , the relaxant effects of Y-27632 were greater in the large artery than in the small artery in both SHR and WKY. The contraction induced by 10 5 or 10 6 mol/l NE was larger in the large artery than in the small artery in both strains. Moreover, in the four arteries tested, the relaxant effects of Y-27632 were dependent on the concentrations of NE used.
Effects of Y-27632 on the Concentration-Response Curve for NE
The cumulative addition of NE (10 9 -10 4 mol/l) caused a concentration-dependent contraction in strips of small and large arteries from SHR and WKY (Fig. 6 ). In the small arteries, the maximum contraction and the pD2 value for NE were not significantly different between SHR and WKY (Fig. 6, Table 2 ). Effects of the pre-application of Y-27632 (0.3 and 3 µmol/l) on these NE contractions were determined in the small arteries (Fig. 6, Table 2 ). The NE contractions in the small arteries were slightly inhibited only by a high concentration of Y-27632 (3 µmol/l). Judging from the parameters shown in Table 2 , the inhibition was not significantly different between the two strains.
In the large arteries, the maximum NE contraction was significantly larger in SHR than in WKY, but the pD2 value for NE was significantly smaller in SHR (Fig. 6, Table 2 ). The NE contractions in the large arteries were concentration- dependently inhibited by Y-27632 (Fig. 6, Table 2 ). Judging from the parameters shown in Table 2 , the inhibition by 0.3 µmol/l Y-27632 was significantly greater in SHR. The inhibition by 3 µmol/l Y-27632 was also significantly greater in SHR (Fig. 6, Table 2 ). Moreover, the inhibition by Y-27632 of the NE contractions was more evident in the large arteries than in the small arteries, as shown in Fig. 6 and Table 2 . From these results, it is also likely that Y-27632 is more effective when applied after rather than before the NE contraction.
Relaxation Induced by Y-27632 in 65.9 mmol/l K -Contracted Strips Y-27632 also induced a concentration-dependent relaxation in strips precontracted with 65.9 mmol/l K (Fig. 7) . In both small and large arteries, this relaxation was greater in SHR than in WKY (Fig. 8, Table 1 ). This relaxation was greater in the large artery than in the small artery in both strains (Fig. 8, Table 1 ).
Since the magnitude of the contraction induced by 65.9 mmol/l K was similar to that induced by 10 6 mol/l NE in each artery, as shown above, these magnitudes were then compared to that of the relaxation induced by Y-27632. As shown in Table 1 , the relaxant effects of Y-27632 were greater in the K -contracted strips than in the NE-contracted strips in both arteries from both strains. The relaxations induced by Y-27632 were slower in the K -contracted strips (Fig. 7) than in the NE-contracted strips (Fig. 1) .
Relaxation Induced by Nifedipine
The post-application of nifedipine (1-100 nmol/l) caused a concentration-dependent relaxation in strips of small arteries Fig. 1 
Fig. 6. Comparison of the effects of the Y-27632 pre-application on the concentration-response curve for norepinephrine (NE) in strips of small and large mesenteric arteries from SHR and WKY. After determination of the maximum contraction induced by 65.9 mmol/l K , contractile responses to NE were determined in a cumulative fashion. Y-27632 at a concentration of 0.3 µmol/l ( ) or 3 µmol/l ( ) was added 20 min before the determination of the NE contraction ( ; Control). The peak contractions induced by each concentration of NE are expressed as a % of the 65.9 mmol/l K contraction. Data points are the means SEM (n number of preparations).
Fig. 7. Typical recordings of the contractile responses to 65.9 mmol/l K (65.9 K ) and the Y-27632-induced relaxations in strips of small mesenteric arteries from SHR (A, B) and WKY (C, D). Experimental conditions were similar to those shown in
except that the strips were treated with 2 µmol/l phenoxybenzamine to eliminate possible α-adrenoceptor responses to endogenously released NE. (A, C) Contractile responses to 65.9 mmol/l K . (B, D) Y-27632-induced relaxations. After the 65.9 mmol/l K -induced contraction had reached a tonic phase, Y-27632 was added cumulatively. At the end of each experiment, 10 4 mol/l papaverine (Pap) was added to identify the position of the maximum relaxation.
precontracted with 10 6 mol/l NE (Fig. 9) . This relaxation was greater in SHR than in WKY (Fig. 9) . Similarly, in the large arteries, the relaxation induced by nifedipine in the NEcontracted strips was greater in SHR (Fig. 9 ). This relaxation in SHR, however, was not significantly different between the small and large arteries (Fig. 9) . On the other hand, nifedipine induced a concentration-dependent relaxation in strips of small and large arteries precontracted with 65.9 mmol/l K (Fig. 9) . Although the nifedipine relaxation was more evident in the K contraction than in the NE contraction in each artery, the relaxation in the K contraction was not significantly different among the four arteries (Fig. 9) . Thus, the relaxant effects of nifedipine were different from those of Y-27632. Furthermore, the relaxations induced by nifedipine were faster than those induced by Y-27632 (data not shown).
Discussion
Y-27632 is described as a highly specific inhibitor of Rho kinase; the affinity of Y-27632 for Rho kinase is ~200 times higher than the affinity of Y-27632 for protein kinase C or cAMP-dependent protein kinase, and over 2,000 times higher than the affinity of Y-27632 for MLCK, respectively (7) . In the concentration range of 0.1 to 10 µmol/l, Y-27632 is reported to induce a stronger relaxation in rabbit aortic strips precontracted with phenylephrine, an α-adrenoceptor agonist, than in those precontracted with K -depolarization, suggesting that the activation of Rho kinase is involved in the phenylephrine-induced contraction (7) . Moreover, since Y-27632 is reported to decrease the blood pressure in several hypertensive rat models, including SHR, it is suggested that the activation of Rho kinase in arterial smooth muscle is involved in the pathophysiology of hypertension (7) . However, the effects of Y-27632 on isolated resistance arteries have never been determined in SHR.
In the present study, we determined the profile of arterial relaxant effects of Y-27632 in strips of small and large mesenteric arteries from SHR. The major findings were 1) Y-27632 induced a relaxation in strips precontracted with either NE or K -depolarization; 2) although the relaxant effects of Y-27632 depended on the concentrations of NE used, these effects were greater in SHR than in WKY; 3) the relaxant effects of Y-27632 in the K -contracted strips were also greater in SHR than in WKY; 4) when the effects of Y-27632 were compared between the large and small arteries, the effects were more evident in the former; and 5) when the effects of Y-27632 were compared between the NE-and Kcontracted strips, the effects were more evident in the latter. These findings further suggest that the function of the Rho/Rho kinase pathway was increased 1) in the SHR arteries compared with the WKY arteries; 2) in the large artery compared with the small artery; and 3) in the K contraction compared with the NE contraction.
Based on the findings that, although the relaxant effects of Y-27632 depended on the concentrations of NE used, these effects were greater in SHR than in WKY in both small and large arteries, we conclude that the function of Rho kinase was increased in the SHR arteries compared with the WKY arteries. The increased relaxant effects of Y-27632 in the arteries from hypertensive rat models have also been shown in the basilar artery from SHR (12) and the large mesenteric artery from mineralocorticoid hypertensive rats (13). Mukai et al. (14) reported that hydroxyfasudil, another specific inhibitor of Rho kinase, preferentially and significantly inhibited the contractile responses of the coronary, carotid and small mesenteric arteries to phenylephrine and serotonin in SHR, but not those in WKY. These authors further reported that both the expression and the activity of Rho kinase were augmented in the SHR arteries. Furthermore, Seasholtz et al. (15) reported an increased expression and activity of RhoA in the aorta and tail arteries from SHR. From these findings, it can be concluded that the function of the Rho/Rho kinase pathway was increased in the SHR arteries compared with the WKY arteries. Since the Rho/Rho kinase pathway is involved in the agonist-induced Ca 2 sensitization of smooth muscle contraction, the present study may support the conclusion by Uehata et al. (7) that the Ca 2 sensitization of arterial smooth muscle is involved in the pathophysiology of hypertension.
The most interesting findings of the present study were that the relaxant effects of Y-27632 were greater in the Kcontracted strips than in the NE-contracted strips in both SHR and WKY. Many studies have shown that Y-27632 induced a weaker relaxation in arterial strips precontracted with K than in those precontracted with receptor agonists (7, 13, (16) (17) (18) . However, some studies have shown that Y-27632 induced similar relaxations between arterial strips precontracted with K and receptor agonists (19) (20) (21) . Anabuki et al. (19) reported that Y-27632 has no effect on the contractions induced by K or carbamylcholine in chicken gizzard smooth muscle. As a positive control, however, they found that Y-27632 inhibits the contractions induced by K or receptor agonist at a similar concentration in rat aorta (19) . Mita et al. (20) reported that RhoA/Rho kinase activation plays an important role in the sustained phase of K -induced contraction in rat tail arterial smooth muscle, but has little involvement in the phasic component of K -induced contraction, based on the relaxant effects of the specific inhibitors of Rho kinase, Y-27632 and HA1077 (fasudil). They also reported that the calculated IC50 values of Y-27632 (0.41 µmol/l) and HA1077 (0.49 µmol/l) needed to relax the K contraction are similar to the previously reported IC50 values of each inhibitor needed to relax agonist-induced contractions. Maeda et al. (21) reported that Y-27632 induced a relaxation in bovine middle cerebral arteries precontracted with K and U46619 (a thromboxane A2 analog), and the relaxation was the same between the two contractions. In addition, it has been shown that HA1077 and its active metabolite, hydroxyfasudil, inhibit the contractions induced by K and receptor agonists (22) (23) (24) . Takizawa et al. (23) reported that the calculated IC50 value of HA1077 needed to induce a relaxation was lower in the 65.4 mmol/l K contraction than in the NE (1 µmol/l) contraction. Based on these data, it is possible that in some arteries, Y-27632 and HA1077 inhibit the contraction induced by K -depolarization to the same or to a greater degree than the contraction induced by receptor agonists. Thus, the inhibitory effect of Y-27632 is not specific for receptor-mediated contraction. Although the mechanism underlying the strong relaxant effects of Y-27632 on the K contraction is not known at the present time, there are at least two possibilities: 1) the Rho/Rho kinase pathway is activated not only by receptor activation but also by K -depolarization, and/or 2) during the K -depolarization, arachidonic acid is released, which activates Rho kinase. Concerning the first possibility, several studies have shown that the K -depolarization increases Ca 2 sensitization of arterial smooth muscle (20, 25, 26) . Furthermore, Sato et al. (27) reported that the K -depolarization increases the Rho kinase activity in dog basilar arteries. Thus, it is likely that Y-27632 can relax the K contraction. Concerning the second possibility, it is well known that arachidonic acid, released by agonists, activates Rho kinase to induce a Ca 2 sensitization of arterial smooth muscle (2, (4) (5) (6) . Moreover, these effects of arachidonic acid were inhibited by Y-27632 (28, 29) . If arachidonic acid is, therefore, released during the K -depolarization, Y-27632 is expected to relax the K contraction. In addition to Rho/Rho kinase and arachidonic acid pathways, protein kinase C might also be a mediator of Ca 2 sensitization of smooth muscle contraction (2, (4) (5) (6) . However, the involvement of the protein kinase C pathway in the relaxant effects of Y-27632 on the K contraction is less likely for the following two reasons: 1) there is no interaction between protein kinase C and Rho kinase; and 2) the concentrations of Y-27632 (0.3-3 µmol/l) used in the present study are too low to inhibit the protein kinase C activity.
SHR are used as an experimental model for human essential hypertension. The primary defect in this model seems to occur in the Ca 2 regulatory system in arterial smooth muscle (30) . A large Ca 2 influx and a high [Ca 2 ]i have been reported even in the resting state of arteries (9, 10, 31, 32) and platelets (33) from SHR when compared with WKY. The finding that Y-27632 strongly inhibited the K contraction may suggest that this agent inhibits Ca As shown in Fig. 6 , the pre-application of Y-27632 was less effective in inhibiting the NE contraction when compared with its high potency in inducing the relaxation. It has previously been shown that Y-27632 is less effective when applied before rather than after the agonist-induced contraction (28, (34) (35) (36) . These results strongly suggest that the tonic phase of the NE contraction is mediated by the Rho/Rho kinase pathway. As shown in the present study, the tonic phase of the NE contraction is larger in the large artery than in the small artery, and this difference may have been related to the difference in the ability of Y-27632 to induce relaxation in the large and in the small arteries.
Taking these results together, we conclude that Y-27632 shows greater relaxant effects on the SHR arteries than on the WKY arteries, and that these effects are more evident in the large artery than in the small artery, and more evident in the K -contracted strips than in the NE-contracted strips. Although the possible mechanism underlying the strong relaxant effects of Y-27632 on the K contraction was not examined in the present study, we propose that the Rho/Rho kinase pathway is activated not only by agonists but also by K -depolarization.
